Background: The aim of this study was to evaluate the expression of IMP3, an independent poor prognostic factor for many cancers, and its association with clinicopathological features and HER2 status.
Methods: Gastrectomy specimens from 106 patients were evaluated by immunohistochemistry and fluorescence in situ hybridization.
Results: HER2 overexpression was found in 4.